1. Home
  2. DARE vs SST Comparison

DARE vs SST Comparison

Compare DARE & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$0.72

Market Cap

13.9M

Sector

Health Care

ML Signal

HOLD

Logo System1 Inc.

SST

System1 Inc.

HOLD

Current Price

$3.83

Market Cap

12.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DARE
SST
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
12.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
DARE
SST
Price
$0.72
$3.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$10.00
$10.00
AVG Volume (30 Days)
768.6K
904.8K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,807,885.00
$266,129,000.00
Revenue This Year
$2,115.12
N/A
Revenue Next Year
$122.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$1.35
52 Week High
$3.78
$9.30

Technical Indicators

Market Signals
Indicator
DARE
SST
Relative Strength Index (RSI) 27.87 80.82
Support Level N/A $2.23
Resistance Level $2.19 $3.72
Average True Range (ATR) 0.07 0.35
MACD 0.01 0.19
Stochastic Oscillator 20.04 92.46

Price Performance

Historical Comparison
DARE
SST

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About SST System1 Inc.

System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.

Share on Social Networks: